Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 8 | 2024 | 1823 | 1.340 |
Why?
|
| Pacemaker, Artificial | 2 | 2024 | 174 | 1.170 |
Why?
|
| Plasma Exchange | 2 | 2018 | 84 | 1.000 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2019 | 460 | 0.970 |
Why?
|
| Anti-Arrhythmia Agents | 4 | 2024 | 224 | 0.960 |
Why?
|
| Atrial Fibrillation | 3 | 2024 | 660 | 0.940 |
Why?
|
| Atrioventricular Block | 1 | 2024 | 38 | 0.860 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2023 | 62 | 0.800 |
Why?
|
| Heart Diseases | 3 | 2018 | 493 | 0.780 |
Why?
|
| Cardiomyopathies | 2 | 2018 | 500 | 0.740 |
Why?
|
| Anticoagulants | 4 | 2022 | 593 | 0.730 |
Why?
|
| Electrocardiography | 4 | 2018 | 979 | 0.710 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2020 | 19 | 0.680 |
Why?
|
| Cardiac Rehabilitation | 1 | 2020 | 25 | 0.660 |
Why?
|
| Cardiac Pacing, Artificial | 2 | 2024 | 117 | 0.660 |
Why?
|
| Heart Valve Prosthesis | 1 | 2023 | 298 | 0.660 |
Why?
|
| Hemorrhage | 2 | 2022 | 469 | 0.610 |
Why?
|
| Factor Xa Inhibitors | 2 | 2018 | 64 | 0.600 |
Why?
|
| Exercise Therapy | 1 | 2020 | 154 | 0.600 |
Why?
|
| Sinus of Valsalva | 1 | 2018 | 35 | 0.600 |
Why?
|
| Death, Sudden, Cardiac | 3 | 2018 | 259 | 0.600 |
Why?
|
| Thromboembolism | 1 | 2018 | 89 | 0.550 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2020 | 256 | 0.540 |
Why?
|
| Stroke | 2 | 2022 | 989 | 0.520 |
Why?
|
| Fontan Procedure | 2 | 2020 | 182 | 0.510 |
Why?
|
| Pulmonary Artery | 2 | 2023 | 443 | 0.500 |
Why?
|
| Cardiac Tamponade | 1 | 2015 | 36 | 0.480 |
Why?
|
| Pericardial Effusion | 1 | 2015 | 64 | 0.470 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2020 | 240 | 0.470 |
Why?
|
| Pyridones | 1 | 2015 | 118 | 0.450 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2018 | 282 | 0.450 |
Why?
|
| Coronary Vessels | 1 | 2018 | 557 | 0.450 |
Why?
|
| Survivors | 1 | 2016 | 339 | 0.440 |
Why?
|
| Tachycardia, Supraventricular | 3 | 2022 | 108 | 0.440 |
Why?
|
| Electric Countershock | 1 | 2014 | 67 | 0.430 |
Why?
|
| Administration, Oral | 3 | 2022 | 684 | 0.410 |
Why?
|
| Pyrazoles | 1 | 2015 | 305 | 0.400 |
Why?
|
| Exercise | 1 | 2018 | 816 | 0.400 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2013 | 157 | 0.370 |
Why?
|
| Electrophysiological Phenomena | 1 | 2011 | 66 | 0.360 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2012 | 105 | 0.350 |
Why?
|
| Heart Rate | 3 | 2024 | 592 | 0.340 |
Why?
|
| Treatment Outcome | 10 | 2024 | 12392 | 0.330 |
Why?
|
| Humans | 30 | 2024 | 125138 | 0.310 |
Why?
|
| Adult | 14 | 2024 | 29634 | 0.310 |
Why?
|
| Cardiac Catheterization | 4 | 2023 | 635 | 0.290 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 1119 | 0.290 |
Why?
|
| Mass Screening | 1 | 2013 | 784 | 0.280 |
Why?
|
| Young Adult | 6 | 2024 | 9056 | 0.280 |
Why?
|
| Retrospective Studies | 9 | 2024 | 16333 | 0.220 |
Why?
|
| Amiodarone | 1 | 2024 | 45 | 0.220 |
Why?
|
| Heart Conduction System | 1 | 2024 | 146 | 0.210 |
Why?
|
| Tricuspid Valve | 1 | 2023 | 59 | 0.200 |
Why?
|
| Mustard Plant | 1 | 2022 | 4 | 0.200 |
Why?
|
| Vacuum Curettage | 1 | 2022 | 5 | 0.200 |
Why?
|
| Male | 13 | 2024 | 61493 | 0.200 |
Why?
|
| Hospitalization | 3 | 2022 | 1781 | 0.200 |
Why?
|
| Sotalol | 2 | 2022 | 33 | 0.200 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 2022 | 22 | 0.190 |
Why?
|
| Adenosine | 1 | 2022 | 127 | 0.180 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 275 | 0.180 |
Why?
|
| Warfarin | 1 | 2022 | 119 | 0.180 |
Why?
|
| Tachycardia, Paroxysmal | 1 | 2020 | 10 | 0.170 |
Why?
|
| Emergency Service, Hospital | 2 | 2018 | 1066 | 0.170 |
Why?
|
| Female | 14 | 2024 | 66771 | 0.170 |
Why?
|
| Time Factors | 4 | 2024 | 6333 | 0.170 |
Why?
|
| Incidence | 3 | 2019 | 3146 | 0.160 |
Why?
|
| Coronary Aneurysm | 1 | 2019 | 33 | 0.160 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 110 | 0.160 |
Why?
|
| Catheter Ablation | 1 | 2022 | 233 | 0.160 |
Why?
|
| Heart Ventricles | 1 | 2024 | 769 | 0.160 |
Why?
|
| Dyspnea | 1 | 2020 | 152 | 0.160 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2020 | 118 | 0.160 |
Why?
|
| Exercise Tolerance | 1 | 2019 | 85 | 0.160 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2019 | 73 | 0.150 |
Why?
|
| Risk Factors | 4 | 2019 | 10309 | 0.150 |
Why?
|
| Nasal Sprays | 1 | 2018 | 8 | 0.150 |
Why?
|
| Hypoxia | 1 | 2020 | 249 | 0.150 |
Why?
|
| Exercise Test | 1 | 2019 | 254 | 0.150 |
Why?
|
| Calcium Channel Blockers | 1 | 2018 | 115 | 0.150 |
Why?
|
| Syncope | 1 | 2018 | 51 | 0.150 |
Why?
|
| Athletic Injuries | 1 | 2018 | 58 | 0.140 |
Why?
|
| Rivaroxaban | 1 | 2018 | 55 | 0.140 |
Why?
|
| Stents | 3 | 2020 | 888 | 0.140 |
Why?
|
| Blood Coagulation | 1 | 2018 | 125 | 0.140 |
Why?
|
| Predictive Value of Tests | 4 | 2019 | 2174 | 0.140 |
Why?
|
| Thrombolytic Therapy | 1 | 2018 | 215 | 0.130 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 236 | 0.130 |
Why?
|
| Tachycardia, Ventricular | 1 | 2018 | 192 | 0.130 |
Why?
|
| Pericardiocentesis | 1 | 2015 | 16 | 0.120 |
Why?
|
| Middle Aged | 6 | 2023 | 26932 | 0.120 |
Why?
|
| Survival Rate | 2 | 2018 | 2063 | 0.120 |
Why?
|
| Defibrillators, Implantable | 1 | 2017 | 190 | 0.120 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2014 | 44 | 0.110 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2014 | 40 | 0.110 |
Why?
|
| Adolescent | 4 | 2022 | 19348 | 0.110 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2014 | 133 | 0.100 |
Why?
|
| United States | 4 | 2018 | 10916 | 0.100 |
Why?
|
| Pregnancy | 2 | 2018 | 7201 | 0.100 |
Why?
|
| Transposition of Great Vessels | 1 | 2014 | 133 | 0.100 |
Why?
|
| Athletes | 1 | 2013 | 66 | 0.100 |
Why?
|
| Hospitals, Pediatric | 1 | 2017 | 761 | 0.100 |
Why?
|
| Transducers, Pressure | 1 | 2012 | 12 | 0.100 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2012 | 30 | 0.090 |
Why?
|
| Vascular Access Devices | 1 | 2012 | 35 | 0.090 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 290 | 0.090 |
Why?
|
| Heart Atria | 1 | 2014 | 317 | 0.090 |
Why?
|
| Blood Pressure Determination | 1 | 2012 | 110 | 0.090 |
Why?
|
| Arterial Pressure | 1 | 2012 | 112 | 0.090 |
Why?
|
| Vascular Diseases | 1 | 2012 | 168 | 0.080 |
Why?
|
| Echocardiography | 1 | 2015 | 1054 | 0.080 |
Why?
|
| Aged | 5 | 2022 | 19871 | 0.080 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2014 | 731 | 0.080 |
Why?
|
| Ischemia | 1 | 2012 | 362 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 2056 | 0.070 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 6600 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2020 | 3071 | 0.070 |
Why?
|
| Coronary Artery Disease | 1 | 2014 | 813 | 0.070 |
Why?
|
| Hemodynamics | 1 | 2012 | 850 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 2102 | 0.070 |
Why?
|
| Prognosis | 2 | 2014 | 4642 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2011 | 1895 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 1271 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 5177 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 1696 | 0.060 |
Why?
|
| Age Factors | 1 | 2011 | 2821 | 0.060 |
Why?
|
| Heart-Assist Devices | 1 | 2013 | 1025 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 3572 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2012 | 3465 | 0.050 |
Why?
|
| Infant | 3 | 2022 | 12484 | 0.040 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2018 | 61 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2018 | 143 | 0.040 |
Why?
|
| Syndrome | 1 | 2020 | 1120 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2022 | 1179 | 0.030 |
Why?
|
| Equipment Failure | 1 | 2017 | 121 | 0.030 |
Why?
|
| Electrodes, Implanted | 1 | 2017 | 168 | 0.030 |
Why?
|
| Length of Stay | 1 | 2022 | 1309 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2017 | 260 | 0.030 |
Why?
|
| Reimbursement Mechanisms | 1 | 2014 | 36 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2018 | 1638 | 0.030 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2014 | 26 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2014 | 285 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2019 | 14010 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2014 | 193 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2022 | 4819 | 0.020 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2012 | 35 | 0.020 |
Why?
|
| Mesenteric Ischemia | 1 | 2012 | 30 | 0.020 |
Why?
|
| Texas | 1 | 2019 | 3588 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2022 | 6158 | 0.020 |
Why?
|
| Patient Selection | 1 | 2014 | 699 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2012 | 240 | 0.020 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2014 | 253 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2017 | 3300 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 1396 | 0.020 |
Why?
|
| Angioplasty, Balloon | 1 | 2012 | 172 | 0.020 |
Why?
|
| Equipment Design | 1 | 2012 | 599 | 0.020 |
Why?
|
| Radiography | 1 | 2012 | 822 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 607 | 0.020 |
Why?
|
| Disease Management | 1 | 2013 | 527 | 0.020 |
Why?
|
| Child | 2 | 2019 | 24389 | 0.020 |
Why?
|